News

Exploring the Intriguing Options Activity of Viking Therapeutics

Exploring the Intriguing Options Activity of Viking Therapeutics

Exploring Options Trading Trends for Viking Therapeutics

In recent times, there has been a notable bearish sentiment surrounding Viking Therapeutics. An examination of options trading history unveils 34 unusual transactions, reflecting a complex interplay of trader sentiment.

Upon closer inspection, we learn that 38% of these traders were inclined towards bullish strategies, while 47% showed signs of bearish movement. Breaking it down further, we see five put trades amounting to $146,300, contrasted with 29 call trades, totaling an impressive $2,404,204.

What Are the Price Targets for Viking Therapeutics?

Analyzing the volume and open interest associated with these contracts, it's clear that significant market players, or whales, have been eyeing a price spectrum ranging from $15.0 to $105.0 in the past three months.

Examining Volume and Open Interest Trends

Evaluating volume and open interest remains crucial when engaging in options trading. Such metrics provide invaluable insight into liquidity and prevailing interest for Viking Therapeutics’ stock options at various strike prices. Over the last month, we’ve witnessed notable fluctuations in these metrics.

Snapshot of Viking Therapeutics' 30-Day Options Volume and Interest

The following data showcases key findings in terms of volume and interest for calls and puts in the options trading realm for Viking Therapeutics.

Highlights of Recent Options Trades

The largest observed trades include several significant movements, portraying the sentiment and strategies of traders actively involved:

  • Symbol: VKTX, Type: CALL, Trade Type: TRADE, Sentiment: BULLISH, Expiration Date: 12/20/24, Price: $8.9, Strike Price: $75.00, Total Trade Value: $213.6K
  • Symbol: VKTX, Type: CALL, Trade Type: SWEEP, Sentiment: BULLISH, Expiration Date: 01/16/26, Price: $61.34, Strike Price: $15.00, Total Trade Value: $191.7K
  • Symbol: VKTX, Type: CALL, Trade Type: TRADE, Sentiment: NEUTRAL, Expiration Date: 12/20/24, Price: $7.8, Strike Price: $77.50, Total Trade Value: $187.2K
  • Symbol: VKTX, Type: CALL, Trade Type: SWEEP, Sentiment: BULLISH, Expiration Date: 01/17/25, Price: $25.5, Strike Price: $50.00, Total Trade Value: $127.5K
  • Symbol: VKTX, Type: CALL, Trade Type: TRADE, Sentiment: BEARISH, Expiration Date: 01/17/25, Price: $25.4, Strike Price: $50.00, Total Trade Value: $127.0K

Understanding Viking Therapeutics

Viking Therapeutics Inc engages in the development of biopharmaceuticals, concentrating on metabolic and endocrine disorders. Their current pipeline includes the VK2809, VK5211, and VK0214 products. Both VK2809 and VK0214 are designed to be orally active and selective to the thyroid hormone receptor beta, while VK5211 functions as a selective androgen receptor modulator.

Pursuing a more comprehensive view, let’s assess Viking Therapeutics' market performance.

The Current Market Status of Viking Therapeutics

  • At present, VKTX's trading volume has reached 2,977,355, with a current price of $73.47, marking a decline of -1.41%.
  • The Relative Strength Index (RSI) suggests the stock may soon enter an overbought territory.
  • Anticipation is building for the upcoming earnings announcement expected in 99 days.

Analyst Insights on Viking Therapeutics

Recently, two analysts shared their viewpoints on Viking Therapeutics, presenting an average target price of $90.00.

Transforming $1000 into $1270 in just 20 days?

A seasoned options trader, with two decades of experience, has developed a straightforward chart technique indicating optimal buy and sell moments. Following this strategy has historically yielded a 27% profit margin in a span of 20 days. Interested traders are encouraged to stay updated with options activity, utilizing informational resources as they navigate these dynamic trading conditions.

Frequently Asked Questions

What recent trends have emerged in options trading for VKTX?

Recent trends show a significant bearish sentiment with 47% of traders leaning towards bearish trades, while 38% indicated bullish behaviors.

What is the significance of volume and open interest in options trading?

Volume and open interest are critical for understanding market liquidity and current trader interest in a stock’s options, helping to guide trading decisions.

What are the current price targets set for Viking Therapeutics by analysts?

Analysts have recently set an average price target of $90.00 for Viking Therapeutics, reflecting a positive sentiment about its performance.

What are the offerings in Viking Therapeutics' clinical pipeline?

The pipeline includes products focusing on metabolic and endocrine disorders, specifically VK2809, VK5211, and VK0214, all designed to be orally available.

How has Viking Therapeutics performed recently in the stock market?

The current market performance indicates Viking Therapeutics has a trading volume of 2,977,355, with shares priced at $73.47, down by 1.41%.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.